CoChat

Personalized medicine in Europe: not yet personal enough?

Open access
Di Paolo, Antonello, Sarkozy, François, Ryll, Bettina, Siebert, Uwe · 2017 · BMC Health Services Research

The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Personalized medicine has the potential to allow patients to receive drugs specific to their individual disease, and to increase the efficiency of the healthcare system. There is currently no comprehensive overview of personalized medicine, and this research aims to provide an overview of the concept and definition of personalized medicine in nine European countries. METHODS: A targeted literature review of selected health databases and grey literature was conducted to collate information regarding the definition, process, use, funding, impact and challenges associated with personalized medicine. In-depth qualitative interviews were carried out with experts with health technology assessment, clinical provisioning, payer, academic, economic and industry experience, and with patient organizations. RESULTS: We identified a wide range of definitions of personalized medicine, with most studies referring to the use of diagnostics and individual biological information such as genetics and biomarkers. Few studies mentioned patients' needs, beliefs, behaviour, values, wishes, utilities, environment and circumstances, and there was little evidence in the literature for formal incorporation of patient preferences into the evaluation of new medicines. Most interviewees described approaches to stratification and segmentation of patients based on genetic markers or diagnostics, and few mentioned health-related quality of life. CONCLUSIONS: The published literature on personalized medicine is predominantly focused on patient stratification according to individual biological information. Although these approaches are important, incorporation of environmental factors and patients' preferences in decision making is also needed. In future, personalized medicine should move from treating diseases to managing patients, taking into account all individual factors.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12913-017-2205-4

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 49 references

Research works printed but not linked: 3

  1. Personalised medicine - opportunities and challenges for European healthcare. http://ec.europa.eu/research/health/pdf/13th-european-health-forum-workshop-report_en.pdf . Accessed 6 Jan 2015.
  2. Lenz C, Fensch M, Sollano JA. Implementing personalised medicine in clinical practice: Country investments and public-private partnerships in Europe. J für Pharmakologie und Therapie. 2012;21:3–7.
  3. Editorial N. Getting Personal - Targeted therapies work, but need help to fulfil their potential. Nature. 2011;473:253–4.

Cited by

See all 54

Metadata

Authors
Di Paolo, A., Sarkozy, F., Ryll, B., & Siebert, U.
Affiliations
  • Uppsala University (SE)
  • UMIT TIROL - Private University for Health Sciences and Health Technology (AT)
Venue
BMC Health Services Research
Published
2017-04-19
Volume
17
Issue
1
Pages
289-289
ISSN
1472-6963 (ISSN-L)
OpenAlex
W2607503467
Cited by
54
References
47
Citations by year
2026: 3 · 2025: 4 · 2024: 1 · 2023: 4 · 2022: 5 · 2021: 9 · 2020: 14 · 2019: 9 · 2018: 3 · 2017: 2
FWCI
13.75
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • BMC Health Services Research (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Uppsala University Publications (Uppsala University) (submittedVersion, other-oa)
  • CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion, cc-by-nc-nd)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Novartis
Topics
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Pharmaceutical Economics and Policy
Keywords
personalized medicine, patient stratification, biomarkers, genetic testing, patient preferences, health technology assessment, patient segmentation, health-related quality of life, patient involvement in treatment decisions, Europe
MeSH terms
Decision Making, Europe, Forecasting, Humans, Interviews as Topic, Quality of Life, Technology Assessment, Biomedical, Patient Satisfaction, Patient Preference, Precision Medicine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Personalized medicine in Europe: not yet personal enough? https://app.cochat.ai/papers/10.1186/s12913-017-2205-4
The paper
Di Paolo, A., Sarkozy, F., Ryll, B., & Siebert, U. (2017). Personalized medicine in Europe: not yet personal enough? BMC Health Services Research. https://doi.org/10.1186/s12913-017-2205-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.